Trial intelligence / Profile preview

Phase 2b trial of YH14618 in lumbar degenerative disc disease

KCT0001454Phase 2Recruiting

Sponsor
Yuhan
Start
Apr 2015
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of vicatertide in lumbosacral disc disease, sponsored by Yuhan. Started Apr 2015; status: recruiting.

02

Drugs

vicatertide
03

Conditions

lumbosacral disc disease

Beyond the preview

Go deeper on KCT0001454.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0001454.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call